Search ADTX
Aditxt, Inc.
OTC · CIK 1726711
Last close0
Daily change+0.00 (0.00%)
10 Years gain-100.00%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ADTX · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
13.2Momentum
0.0Acceleration
0.0Confidence
75.0Annual Revenue5
Quarterly Revenue14
Annual CFO7
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 389.5303 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 108234.6332 percentage points.
Key Metrics
Revenue Growth TTM-88.86%OK
Revenue CAGR 3Y-84.93%OK
Gross Margin21.21%OK
Operating Margin-129,030.77%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $3,195.00 | $268.00 | -$19.57M | -$25.69M | -$25.70M | 8.39% | -612,542.22% | -804,447.64% | -950.66% | 37,355 |
| 2025 FY Dec 31, 2024 | $133,985.00 | -$493,489.00 | -$27.86M | -$16.76M | n/a | -368.32% | -20,796.13% | n/a | -262.04% | 2 |
| 2024 FY Dec 31, 2023 | $645,176.00 | -$111,660.00 | -$26.06M | -$19.20M | n/a | -17.31% | -4,039.58% | n/a | -223.83% | 1,209 |
| 2023 FY Dec 31, 2022 | $933,715.00 | $166,936.00 | -$25.48M | -$22.39M | -$22.76M | 17.88% | -2,728.89% | -2,437.48% | -848.2% | 46,369 |
| 2022 FY Dec 31, 2021 | $105,034.00 | $27,055.00 | -$41.93M | -$22.28M | n/a | 25.76% | -39,925.1% | n/a | -2,350.07% | 381,811 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $14,929.00 | sum latest 4 fiscal quarters Revenue | OK | 0001213900-26-059562, 0001213900-25-076710 |
| Revenue Growth TTM | -88.86% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-26-059562, 0001213900-25-076710 |
| Revenue CAGR 3Y | -84.93% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-037529 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001213900-26-037529 |
| Gross Profit CAGR 3Y | -88.29% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-037529 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-26-059562, 0001213900-25-076710 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 21.21% | Gross Profit / Revenue | OK | 0001213900-26-059562, 0001213900-25-076710 |
| Operating Margin | -129,030.77% | Operating Income / Revenue | OK | 0001213900-26-059562, 0001213900-25-076710 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001213900-26-059562 |
| Current Ratio | 0.06x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.74 | Revenue / Diluted Shares | OK | 0001213900-26-059562, 0001213900-25-076710 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001213900-26-037529 |